Autistic Disorder Clinical Trial
— PRTGOfficial title:
Pivotal Response Group Treatment for Parents of Young Children With Autism
| NCT number | NCT01881750 |
| Other study ID # | SU-11022010-7151 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | July 2010 |
| Est. completion date | July 2012 |
| Verified date | July 2019 |
| Source | Stanford University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This is a research study examining the effectiveness of pivotal response treatment group (PRTG) in targeting language skills in young children with autism. Research has demonstrated that behavioral interventions, such as Pivotal Response Training (PRT), lead to improvements in the core symptoms of autism. The purpose of this study is to further examine the effectiveness of teaching pivotal response treatment to parents of children with autism in a group format. To determine the effectiveness of pivotal response training group (PRTG) it will be compared to another parent education group by conducting a randomized controlled 12-week trial.
| Status | Completed |
| Enrollment | 53 |
| Est. completion date | July 2012 |
| Est. primary completion date | June 2012 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 2 Years to 6 Years |
| Eligibility |
Inclusion Criteria: - Diagnosis of Autism Spectrum Disorder (ASD) based on Autism Diagnostic Interview - Revised (ADI-R), Autism Diagnostic Observation Schedule (ADOS), Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), and expert clinical opinion - Outpatients between 2.0 and 6 years of age of either gender - Children of all cognitive levels will be included as long as they are able to participate in the testing procedures to the extent that valid standard scores can be obtained - Language delay as measured by the Preschool Language Scale 4th ed. (PLS-4) - Participants must have the ability to make meaningful vocalizations, defined as the ability to make contingent vocalizations when prompted (i.e., vocal sound showing intent to communicate, but not necessarily clear words) - Stable psychotropic medication(s) or biomedical interventions for at least one month prior to baseline measurements with no anticipated changes during study participation - Stable behavioral treatment (Applied Behavioral Analysis, Floortime, or other interventions), speech therapy, and school placement for at least 2 months prior to baseline measurements with no expected changes during study participation - No more than 60 minutes of 1:1 speech therapy per week - The availability of at least one parent who can consistently participate in the group treatment and related activities of the research study - Be male or female in good medical health - Will be starting PRTG after the first magnetic resonance image (MRI) scan has occured and, if agreeable, blood draw or saliva sample - Parents intend on continuing PRTG for a minimum of 12 weeks - Parents must be 18 years of age or older. Exclusion Criteria: - A current or life-time diagnosis of severe psychiatric disorder (e.g., bipolar disorder…) - A genetic abnormality, such as Fragile X, based on genetic testing, done as indicated - Presence of active medical problem (e.g., unstable seizure disorder or heart disease) - Participants taking psychotropic medications will not be included if their medications have not been stable for over a week - Parents who do not have the ability to videotape parent and child interactions on a weekly basis - Parents who are not willing to implement intervention strategies for at least one hour a day - Parents who plan to alternate which parent attends the group sessions. |
| Country | Name | City | State |
|---|---|---|---|
| United States | Stanford University School of Medicine | Stanford | California |
| Lead Sponsor | Collaborator |
|---|---|
| Stanford University | Autism Speaks |
United States,
Gengoux GW, Berquist KL, Salzman E, Schapp S, Phillips JM, Frazier TW, Minjarez MB, Hardan AY. Pivotal Response Treatment Parent Training for Autism: Findings from a 3-Month Follow-Up Evaluation. J Autism Dev Disord. 2015 Sep;45(9):2889-98. doi: 10.1007/s — View Citation
Hardan AY, Gengoux GW, Berquist KL, Libove RA, Ardel CM, Phillips J, Frazier TW, Minjarez MB. A randomized controlled trial of Pivotal Response Treatment Group for parents of children with autism. J Child Psychol Psychiatry. 2015 Aug;56(8):884-92. doi: 10 — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change From Baseline in Communication During Structured Lab Observation (SLO) at 12 Weeks | Total frequency of child's utterances during 10 minute videotaped SLO assessment. | Baseline, 12 weeks | |
| Secondary | Parenting Stress Index Total Score | Higher Scores Mean higher stress level and lower scores mean less stress (Range: Minimum = 36; Maximum=180). | Baseline, 12 weeks | |
| Secondary | Family Empowerment Scale Total Score | Higher Scores Mean better/more empowered and lower scores mean worse/less empowered (Range: Minimum = 24; Maximum=170). | Baseline, 12 weeks | |
| Secondary | Behavior Rating Inventory of Executive Function- Preschool Global Executive Composite Score | Higher scores indicate worse executive functioning and lower scores indicate better executive functioning (Range: Minimum=63; Maximum=189). | Baseline, 12 weeks | |
| Secondary | Repetitive Behavior Scale- Revised Total Score | Higher total scores mean more repetitive behaviors and lower total scores mean fewer repetitive behaviors (Range: Minimum=0; Maximum=129). | Baseline, 12 weeks | |
| Secondary | Sensory Profile Questionnaire Sensory Seeking Raw Score | Higher scores mean more typical sensory seeking behaviors and lower scores mean more abnormal sensory seeking behaviors (Range: Minimum=0; Maximum=85). | Baseline, 12 weeks | |
| Secondary | Pediatric Quality of Life Scale Scaled Total Mean Score | Higher scores mean better quality of life and lower scores mean worse quality of life (Range: Minimum=0; Maximum=100). | Baseline, 12 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03222375 -
SQUEDâ„¢ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
|
N/A | |
| Completed |
NCT02568631 -
Improving Social Cognition for Adults With ASD by the Serious Game JeStiMulE Versus Controls
|
N/A | |
| Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
| Completed |
NCT02369445 -
Investigation of Teacher-Mediated Toilet Training Using a Manualized Moisture Alarm Intervention
|
N/A | |
| Completed |
NCT01617460 -
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
|
Phase 3 | |
| Completed |
NCT01592747 -
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
|
Phase 2 | |
| Completed |
NCT01400269 -
An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism
|
N/A | |
| Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
| Completed |
NCT00926471 -
Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders
|
Phase 1 | |
| Completed |
NCT00692315 -
Treating Oxidative Stress in Children With Autism
|
N/A | |
| Completed |
NCT00365859 -
Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
|
Phase 3 | |
| Completed |
NCT00198107 -
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
|
Phase 3 | |
| Completed |
NCT00095420 -
Relationship Training for Children With Autism and Their Peers
|
N/A | |
| Completed |
NCT00027404 -
Study of Fluoxetine in Adults With Autistic Disorder
|
N/A | |
| Recruiting |
NCT05910502 -
Project AFECT (Autism Family Empowerment Coaching and Training Program)
|
N/A | |
| Completed |
NCT04820998 -
Living in a Precarious Situation With an Autistic Child: What Are the Issues at Stake for Support in Care
|
||
| Withdrawn |
NCT05413187 -
A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder
|
Phase 2 | |
| Recruiting |
NCT02275455 -
Design Of WELL Being Monitoring Systems, Application in Autism
|
N/A | |
| Completed |
NCT02766101 -
Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges
|
N/A | |
| Completed |
NCT01977248 -
Sensorimotor Affect Relationship-based Therapy (SMART) for Children With Autism Spectrum Disorders Ages 2-12
|
N/A |